- Research works
- 31 ◆ 0% vs 2013–17
- Citations
- 497 16.1 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 19% world 28%
Not ranked overall: Viventia Bio (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at Viventia Bio (Canada)?
Ranked on the composite score, Mark Kowalski lead among researchers whose main affiliation is Viventia Bio (Canada).
- 1 Mark Kowalski Canada · #1,053,585 worldwide 29 citations · 15 works
Which keywords describe research at Viventia Bio (Canada)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Glycosylation, Targeted Therapy, Immunotoxin, Ricin Poisoning, Monoclonal Antibodies, Therapeutic Antibodies and Antibody Engineering.
- Bacteriophage
- Glycans
- Nanoparticles
- Cancer Immunotherapy
- Genomics
- Bacterial Therapy
- Tumor Targeting
- Tumor Regression
- Vaccine Antigens
- Recombinant Proteins
- Immunotherapy
- Antibody Engineering
- Monoclonal Antibodies
- Immunotoxin
- Glycosylation
- Cancer Therapy
- Targeted Therapy
- Ricin Poisoning
- Therapeutic Antibodies
- Fc Receptors
- Biopharmaceuticals
- Plant Molecular Farming
- Cancer
- Gene Therapy
- Arginine Deprivation
- Chemotherapy
- Virus
- Microbiome
- Therapy
- Immune System
- Ecology
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 31 words, with their numbers
- Cancer Therapy7▲ 34×4 topics
- Glycosylation6▲ 91×3 topics
- Targeted Therapy6▲ 93×2 topics
- Immunotoxin6▲ 624×1 topic
- Ricin Poisoning6▲ 624×1 topic
- Monoclonal Antibodies5▲ 119×2 topics
- Therapeutic Antibodies5▲ 133×2 topics
- Antibody Engineering5▲ 162×1 topic
- Fc Receptors5▲ 162×1 topic
- Immunotherapy4▲ 19×7 topics
- Biopharmaceuticals3▲ 140×2 topics
- Recombinant Proteins3▲ 179×2 topics
- Plant Molecular Farming3▲ 354×1 topic
- Vaccine Antigens3▲ 354×1 topic
- Cancer3▲ 5.9×8 topics
- Tumor Regression2▲ 94×2 topics
- Gene Therapy2▲ 24×2 topics
- Tumor Targeting2▲ 44×3 topics
- Arginine Deprivation2▲ 123×1 topic
- Bacterial Therapy2▲ 123×1 topic
- Chemotherapy2▲ 7.2×4 topics
- Genomics1▲ 12×2 topics
- Virus1▲ 36×2 topics
- Cancer Immunotherapy1▲ 27×2 topics
- Microbiome1▲ 26×2 topics
- Nanoparticles1▲ 3.0×4 topics
- Therapy1▲ 18×2 topics
- Glycans1▲ 44×1 topic
- Immune System1▲ 11×1 topic
- Bacteriophage1▲ 49×1 topic
- Ecology1▲ 16×1 topic
Which research topics does Viventia Bio (Canada) publish most on?
By volume in 2022–2025: Plant and Biological Electrophysiology Studies, Smart Agriculture and AI and Tree Root and Stability Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Plant and Biological Electrophysiology Studies Plant Science 0 works
- 2 Smart Agriculture and AI Plant Science 0 works
- 3 Tree Root and Stability Studies Mechanical Engineering 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Viventia Bio (Canada)'s research output changed?
Output in 2018–2022 was 0% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Winnipeg
- University of Manitoba
- Health Sciences Centre
- University of Winnipeg
- St. Boniface Hospital
- Research Manitoba
- Agriculture Food and Rural Development
- Manitoba Health
- CancerCare Manitoba
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.